Difference between revisions of "Non-small cell lung carcinoma"

Jump to navigation Jump to search
no edit summary
 
(4 intermediate revisions by the same user not shown)
Line 39: Line 39:
In the clinical context, it is often referred to as '''non-small cell lung cancer'''; this ignores the fact that not all non-small cell lung cancer fits into the [[carcinoma]] category.
In the clinical context, it is often referred to as '''non-small cell lung cancer'''; this ignores the fact that not all non-small cell lung cancer fits into the [[carcinoma]] category.


''Poorly differentiated carcinoma of the lung'' and ''poorly differentiated lung carcinoma'' redirect to this article.
''Poorly differentiated carcinoma of the lung'', ''non-small cell carcinoma'' and ''poorly differentiated lung carcinoma'' redirect to this article.


==General==
==General==
Line 69: Line 69:


===Grading===
===Grading===
*NSCC-NOS, NSCC-favour adenocarcinoma, NSCC-favour SCC are grade 4.
*''NSCC-NOS'', ''NSCC favour adenocarcinoma'', ''NSCC favour SCC'' are grade 4.


Note:
Note:
Line 89: Line 89:


Note:
Note:
*Immunostains should not favour adenocarcinoma or squamous cell carcinoma - see ''Sloan-Kettering algorithm'' below.
*If immunostains favour adenocarcinoma or squamous cell carcinoma, the case should be sign as ''favour adenocarcinoma'' or ''favour squamous cell carcinoma'', see ''Sloan-Kettering algorithm'' below and ''Sign out'' section.


===Adenocarcinoma versus squamous carcinoma===
===Adenocarcinoma versus squamous carcinoma===
Line 122: Line 122:
|-
|-
| Non-small cell carcinoma, favour adenocarcinoma
| Non-small cell carcinoma, favour adenocarcinoma
| TTF-1 or napsin +ve
| [[TTF-1]] or napsin +ve
|-
|-
| Non-small cell carcinoma, favour squamous cell carcinoma
| Non-small cell carcinoma, favour squamous cell carcinoma
| p40 or p63 +ve
| [[p40]] or [[p63]] +ve
|-
|-
| Non-small cell carcinoma-not otherwise specified
| Non-small cell carcinoma-not otherwise specified
49,259

edits

Navigation menu